Evidence-based data for newly approved medications' use in older adults: An analysis from clinical trials to monographs.

Newly marketed medications still appear to under-represent older adults. The resulting lack of clear recommendations in monographs compromises evidence-based practice, thereby perpetuating the risk to older adults' health.